Doubling down as a different PBM

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right

August 1, 2024

Reimagining pharmacy

In light of recent media and legislative attention on our industry, I’ve been thinking a lot about what makes Prime Therapeutics/Magellan Rx (Prime/MRx) so different from other pharmacy benefit managers. First, it’s our people. Each and every employee is dedicated to our purpose of providing the same care we would want for our loved ones. But it’s also about our business model.

At Prime/MRx, we are firmly committed to doing what is in the best interest of our clients and members, delivering affordability and transparency while working to improve health outcomes and experiences. This guiding principle drives how we serve clients and members every day, and I am incredibly proud of the important work we do as we live out our mission to reimagine pharmacy.

Some key areas of distinction for Prime/MRx include:

  • Our focus on purpose beyond profits. Being privately held by a consortium of mission-driven partners allows us to invest in long-term solutions. We’re not publicly traded or owned by a private equity firm. As such, it is not our primary motivation to maximize profits; our primary motivation is to do the right thing.
  • Our conflict-free approach. We are not incentivized to direct members to visit physician groups we own or fill prescriptions at pharmacies that we own. Instead, we work collaboratively with many providers and pharmacies through numerous distribution channels to help those we serve choose the best path for their needs while focusing our energy on making drugs more affordable and accessible for our members.
  • Our cross-benefit management and specialty expertise. We take a holistic view of care to help manage the most complex conditions and expensive specialty drugs. We have deep in-house medical pharmacy experience, clinical expertise and the ability to deliver therapy-specific care that helps us lower the total cost of care and improve member experiences and health outcomes.

Prime/MRx is a very special place — We are distinctly different in the way we function, from our purpose and operating model to our capabilities, innovation and outcomes. We are committed to trust and transparency. We work consultatively with our clients to understand their unique needs and construct our financial arrangements to provide transparency and pass-through savings. This means we’re helping to make prescription drugs more affordable for our clients and their members. I feel proud and confident in our unique business model, the work we do and the way we set ourselves apart from the rest.

Related news

Perspectives

August 14, 2024

September 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market

Perspectives

August 1, 2024

LISTEN NOW: Weight management — A holistic journey | Pharmacy Friends podcast

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Perspectives

July 31, 2024

Drug Approvals Quarterly Update: July 2024

This wrap-up provides a review of newly approved drugs, recent drug launches, new…